Turning patients from passive recipients of therapeutic products into well-informed users of them is of capital importance. To take this development into account, Swissmedic is revisiting its collaboration with the relevant stakeholder groups.
In doing so, the following objectives are at the forefront:
- The proactive provision of information on all aspects of therapeutic products, in a form adapted to the needs of patients and consumers;
- The use of appropriate methods of communication;
- The involvement of representatives of patient and consumer organisations in certain identified areas of Swissmedic's activity.
The active involvement of representatives of patient and consumer organisations in some areas of Swissmedic's activity is a gradual process in order for both Swissmedic and the organisations to gain the necessary experience.
In a first step, Swissmedic is establishing a pilot working group for a two-year period, consisting of representatives of patient and consumer organisations and of Swissmedic.
The working groupm is a platform for the exchange of information and experiences among the participants. The opinions and experience of patients and consumers regarding issues related to therapeutic products will therefore be heard, noted, and may be included in Swissmedic's processes. The group will also constitute an appropriate forum for information to be provided in a suitable form with a view to enhancing the participants' awareness of the Agency's tasks and responsibilities.
As Switzerland's national authority for therapeutic products, Swissmedic works with organisations that are established in Switzerland.
Interested organisations may apply to join this working group